MS Insights

MRI review

New Perspectives on Diagnosing Multiple Sclerosis

A majority of the time, the diagnosis of progressive multiple sclerosis (MS) is retrospective, despite better drugs to counteract the progression of the disease in patients who are diagnosed early.  In MS and other rare diseases that are not supported by scientific consensus confirming their etiology, physicians have often opted for a “wait-and-see” approach to…

Proteomics

Proteomics and Multiple Sclerosis: Where Do We Stand?

The wish for reliable biomarkers is particularly evident in diseases clinically silent in the early stages, as seems to be the case in multiple sclerosis (MS). In fact, in a recent study published in Neurology, Gasperi et al concluded that “patients with MS are frequently not diagnosed at their first demyelinating event but often years later.…

Next post in Insights